Studies suggest that HTLV-1 asymptomatic carriers and healthy controls have higher concentrations of Foxp3+ Tregs versus HAM/TSP patients, supporting that Tregs assist in mitigating the immune response. Here, FOXP3 is linked to tropical spastic paraparesis.